1DH1 and TIBSOVO® (ivosidenib) By Steve|2019-08-14T05:46:54+12:00August 14th, 2019|All, IMMUNOTHERAPY, TRIALS| Read More 0
Dr Charles Drake explains about Exhausted T Cells By Steve|2018-10-15T21:16:12+13:00October 15th, 2018|All, TRIALS| Read More 2
Cholangiocarcinoma Patient- Steve Holmes – One Year on Keytruda By Steve|2019-08-09T04:33:22+12:00September 3rd, 2018|Archived, IMMUNOTHERAPY, PATIENT, TRIALS| Read More 0
Investigating the Biliary RFA Procedure By Steve|2018-08-29T02:00:04+12:00August 29th, 2018|All, SURGERY, TRIALS| Read More 0
Medical advances improve Cholangiocarcinoma outcomes By Steve|2018-08-27T06:29:54+12:00August 27th, 2018|IMMUNOTHERAPY, TRIALS, Videos| Read More 0
Cholangiocarcinoma and immunotherapy with Hoosier Cancer Research By Steve|2018-08-19T03:18:43+12:00August 18th, 2018|IMMUNOTHERAPY, TRIALS, Videos| Read More 0
Cholangiocarcinoma Trial decision making – Navigating the Clinical Trials Maze By Steve|2018-08-27T07:10:58+12:00August 18th, 2018|TRIALS| Read More 0
Cholangiocarcinoma Treatment lmproving By Steve|2018-08-15T05:26:40+12:00August 15th, 2018|All, IMMUNOTHERAPY, TRIALS| Read More 2
Adrienne Skinner Cholangiocarcinoma and Keytruda By Steve|2019-07-23T08:32:40+12:00August 1st, 2018|All, IMMUNOTHERAPY, PATIENT, TRIALS, Videos| Read More 0
Keytruda works on Cholangiocarcinoma Patient By Steve|2019-03-31T11:19:16+13:00August 1st, 2018|All, IMMUNOTHERAPY, PATIENT, TRIALS| Read More 0
Vyriad Expands Phase 1 Trial to Test Voyager-V1 By Steve|2018-07-28T06:11:12+12:00July 28th, 2018|All, IMMUNOTHERAPY, Media, TRIALS| Read More 0